首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 製藥 > 感染疾病 > 印尼B型肝炎治療之機會評估
產業/市場分類
製藥 (4816)
肥胖症治療 (44)
非專利藥 (129)
疫苗 (181)
神經疾病 (172)
骨頭疾病治療 (37)
動物用醫藥 (17)
處方藥 (156)
規章 (126)
感染疾病 (346)
精神病 (84)
製藥企業 (524)
糖尿病 (191)
癌症 (909)
藥物開發 (1449)
DDS (182)
OTC 非處方藥 (150)
市場調查報告書

印尼B型肝炎治療之機會評估

Opportunities Assessment for Hepatitis B Therapeutics Market in Indonesia

出版商 Frost & Sullivan
出版日期 2009年03月 商品編碼 83700
內容資訊 英文 36 Pages
價格
US $ 6000 Web Access (Regional License)
US $ 6500 Hard Copy & Web Access (Regional License)


印尼B型肝炎治療之機會評估 是由出版商Frost & Sullivan在2009年03月所出版的。 這份英文市場調查報告書包含36 Pages 價格從美金6000起跳。

目錄

Abstract

This research service aims to provide an update on the epidemiology of hepatitis B, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the diabetes therapeutics market in Indonesia.

Table of Contents

1. EXECUTIVE SUMMARY

Market Overview

  • Hepatitis B Therapeutics Executive Summary

2. HEPATITIS B THERAPEUTICS MARKET

Market Overview

  • Introduction
  • Context for the Study
  • Geographic Scope and Methodology
  • Restraints in Forecasts

3. INDONESIAN HEPATITIS B THERAPEUTICS MARKET

Market Overview

  • Introduction
  • Market Engineering Measurements
  • Government Initiatives

Market Forecasts and Trends

  • Patient Forecasts
  • Cost of Treatment
  • Treatment and Diagnosis
  • Clinical Trials

Competitive Analysis

  • Competitive Structure
  • Market Share Analysis
  • Future Trends
  • Challenges Faced by Physicians

4. APPENDIX

Appendices Hepatitis B Indonesia

  • Total Population and Growth Rate
  • Access Population and Percent of Total Population
  • Carriers of HBV and Percent of Access Population
  • Total CHB Patients and Percent of Carriers of HBV
  • Diagnosed Patients and Percent of CHB Patients
Back to Top